• Metabolomics Reveals Biomarkers of Carbapenemase Resistance

  2026-05-27

  This study demonstrates that LC-MS/MS metabolomic profiling can accurately distinguish carbapenemase-producing Enterobacterales (CPE) from non-resistant strains using characteristic metabolic signatures. The findings offer a fast, mechanistically-informed alternative for CPE detection and have significant implications for antibiotic resistance research and diagnostic assay development.

• Cycloheximide in Translational Research: Mechanisms and Stra

  2026-05-26

  Explore the strategic deployment of Cycloheximide as a precision protein biosynthesis inhibitor in advanced translational research. This thought-leadership article unpacks the molecular rationale, competitive landscape, and translational value of Cycloheximide, drawing on new mechanistic insights—such as the interplay of SUMOylation and ubiquitination in mucosal repair—while providing actionable guidance for protocol optimization and robust experimental design. Distinct from typical product pages, this piece bridges mechanistic discovery with workflow innovation, supporting researchers in dissecting dynamic protein turnover, cell death, and tissue repair processes.

• Molnupiravir Protects Mice from Bourbon Virus: Efficacy and

  2026-05-26

  This study demonstrates that molnupiravir, a nucleoside analogue, effectively inhibits Bourbon virus (BRBV) replication and mitigates disease in a lethal mouse model. The findings offer critical preclinical evidence for repurposing broad-spectrum antivirals against emerging tick-borne RNA viruses lacking approved therapies.

• Practical Guidance for Cathepsin B Inhibitor CA-074 (A1926)

  2026-05-25

  Cathepsin B inhibitor CA-074 (A1926) is a selective tool for dissecting the roles of cathepsin B in cancer metastasis, neurotoxicity, and immune modulation. It is best suited for experiments demanding high specificity and minimal off-target inhibition, but should not be used where pan-cathepsin inhibition or long-term solution stability is required.

• Prostaglandin E2: Beyond Inflammation—Immunity, Assay Precis

  2026-05-25

  Explore how Prostaglandin E2 (PGE2) advances immune regulation, assay design, and translational research. Discover unique mechanistic insights and practical protocol guidance for precision experimental workflows.

• Prostaglandin E2: Precision Workflows for Inflammation Resea

  2026-05-24

  Prostaglandin E2 (PGE2) stands at the forefront of inflammation and immune regulation research, offering reproducible, high-fidelity results across diverse experimental models. This article translates advanced bench protocols and troubleshooting strategies into actionable workflows—empowering researchers to leverage APExBIO’s PGE2 for gastrointestinal protection, reproductive medicine, and beyond.

• High Extracellular Viscosity Drives Chemoresistance via P-gp

  2026-05-23

  This study reveals that high-viscosity tumor microenvironments can directly promote chemoresistance in cancer cells by mechanically inducing P-glycoprotein (P-gp) expression via TRPV4-YAP signaling. These findings highlight a novel mechanobiological axis underlying transporter-mediated drug resistance, offering new avenues for targeted research and potential intervention strategies.

• Applied Use of (S)-1-(3-fluoro...) Urea in sEH/Nrf2 Pathway

  2026-05-22

  Harness the unique solubility and purity of (S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea for robust redox and signaling pathway research. This guide details workflow upgrades, troubleshooting, and bench-tested protocol parameters, optimized from the latest sEH–Nrf2 axis insights.

• Formononetin Mitigates Oxaliplatin Neurotoxicity via Nrf2/HO

  2026-05-22

  This study identifies formononetin as a neuroprotective agent that reduces oxaliplatin-induced peripheral neurotoxicity in neuronal models by activating the Nrf2/HO-1 antioxidant pathway, without diminishing anticancer efficacy. The results offer new insights for managing chemotherapy-induced neuropathy without compromising treatment outcomes.

• Live-Dead Bacterial Staining Kit: Precision Viability Assess

  2026-05-21

  The Live-Dead Bacterial Staining Kit provides dual-fluorescent viability staining for bacteria, using NucGreen dye and EthD-III to distinguish live from dead cells with high specificity. This enables robust bacterial viability assays for microbiology research and nanomaterial-driven infection models.

• Thermogenic Capacity in Lactating Hamsters Under Extreme Col

  2026-05-21

  This study demonstrates that lactating striped hamsters (Cricetulus barabensis) maintain their thermogenic capacity during acute exposure to extreme cold, challenging the prevailing assumption that lactation compromises cold tolerance. These findings clarify physiological adaptation during reproduction and inform experimental design for researchers studying metabolic stress in small mammals.

• Meropenem Trihydrate: Applied Workflows in Antibiotic Resist

  2026-05-20

  Meropenem trihydrate empowers researchers to dissect resistance phenotypes and optimize infection modeling with robust, reproducible protocols. This article delivers actionable guidelines for experimental workflows, troubleshooting, and future-ready assay design, leveraging the latest metabolomics insights and APExBIO’s trusted supply.

• Macromolecular Cryoprotectants Enhance THP-1 Post-Thaw Diffe

  2026-05-20

  This study presents a breakthrough in the cryopreservation of THP-1 monocytes by employing macromolecular cryoprotectants that mitigate intracellular ice formation. The approach doubles post-thaw recovery and preserves macrophage differentiation capacity, streamlining high-throughput immunological assays.

• CGP 55845 Hydrochloride: Precision in GABAB Receptor Antagon

  2026-05-19

  CGP 55845 hydrochloride brings unparalleled selectivity and performance to advanced GABAB receptor antagonist studies, empowering reproducible in vitro investigations into synaptic transmission and neurotransmitter release. Integrating recent astrocyte-GABA signaling breakthroughs, this compound from APExBIO is the benchmark for dissecting complex neural circuits and optimizing experimental workflows.

• Metabolomics Signatures of Carbapenemase-Producing Enterobac

  2026-05-19

  This article discusses a 2025 study that used LC-MS/MS metabolomics to distinguish carbapenemase-producing Enterobacterales (CPE) from non-CPE strains. By identifying metabolic biomarkers and pathway alterations, the work advances rapid resistance phenotyping and highlights new diagnostic opportunities for antibiotic resistance research.

556 records 17/38 page Previous Next First page 上5页 1617181920 下5页 Last page